Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Deferred Tax Liability (2016 - 2018)

Apyx Medical filings provide 7 years of Non-Current Deferred Tax Liability readings, the most recent being $368000.0 for Q2 2018.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 34.75% to $368000.0 in Q2 2018 year-over-year; TTM through Jun 2018 was $368000.0, a 34.75% decrease, with the full-year FY2017 number at $368000.0, down 34.75% from a year prior.
  • Non-Current Deferred Tax Liability hit $368000.0 in Q2 2018 for Apyx Medical, roughly flat from $368000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $564000.0 in Q4 2015 to a low of $368000.0 in Q4 2017.
  • Median Non-Current Deferred Tax Liability over the past 4 years was $564000.0 (2015), compared with a mean of $490500.0.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: changed 0.0% in 2016 and later crashed 34.75% in 2017.
  • Apyx Medical's Non-Current Deferred Tax Liability stood at $564000.0 in 2015, then changed by 0.0% to $564000.0 in 2016, then tumbled by 34.75% to $368000.0 in 2017, then changed by 0.0% to $368000.0 in 2018.
  • The last three reported values for Non-Current Deferred Tax Liability were $368000.0 (Q2 2018), $368000.0 (Q1 2018), and $368000.0 (Q4 2017) per Business Quant data.